Amgen (AMGN) stock Forecast for 2022 – 2026
Last update: 05-24-2022, 9:24
Sector: HealthcareThe share price of Amgen Inc. (AMGN) now
What analysts predict:: $249.25
52-week high/low: $256.39 / $195.38
50/200 Day Moving Average: $241.44 / $224.7
This figure corresponds to the average price over the previous 50/200 days. For Amgen stocks, the 50-day moving average is the support level today.
For Amgen stocks, the 200-day moving average is the support level today.
Are you interested in Amgen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Amgen stock price in 2022, 2023, 2024, 2025, 2026. How much will one Amgen share be worth in 2022 - 2026?
When should I take profit in Amgen stock? When should I record a loss on Amgen stock? What are analysts' forecasts for Amgen stock? What is the future of Amgen stock?
We forecast Amgen stock performance using neural networks based on historical data on Amgen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Amgen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Amgen shares. This happens once a day.
Historical and forecast chart of Amgen stock
The chart below shows the historical price of Amgen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Amgen stock price can be found in the table below.
Long-term forecasts by years.
Amgen daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 26 | 249.90 | 245.65 | 252.66 | 2.85 |
| May 27 | 248.81 | 247.49 | 250.70 | 1.29 |
| May 28 | 243.31 | 240.35 | 246.90 | 2.72 |
| May 29 | 241.97 | 238.19 | 246.26 | 3.39 |
| May 30 | 247.31 | 244.70 | 248.62 | 1.60 |
| May 31 | 244.75 | 240.64 | 247.91 | 3.02 |
| Jun 01 | 242.95 | 240.66 | 245.30 | 1.93 |
| Jun 02 | 242.39 | 238.10 | 243.62 | 2.32 |
| Jun 03 | 239.16 | 237.13 | 243.07 | 2.51 |
| Jun 04 | 233.71 | 230.33 | 237.16 | 2.96 |
| Jun 05 | 231.35 | 228.37 | 233.64 | 2.31 |
| Jun 06 | 233.21 | 230.37 | 234.93 | 1.98 |
| Jun 07 | 231.92 | 227.98 | 235.02 | 3.09 |
| Jun 08 | 230.06 | 228.36 | 231.49 | 1.37 |
| Jun 09 | 233.07 | 229.32 | 235.59 | 2.74 |
| Jun 10 | 235.06 | 231.43 | 239.22 | 3.36 |
| Jun 11 | 238.41 | 235.01 | 240.71 | 2.43 |
| Jun 12 | 240.71 | 238.11 | 244.53 | 2.70 |
| Jun 13 | 241.21 | 238.38 | 242.87 | 1.88 |
| Jun 14 | 235.66 | 233.22 | 236.96 | 1.60 |
| Jun 15 | 236.75 | 234.84 | 240.29 | 2.32 |
| Jun 16 | 233.75 | 232.46 | 235.53 | 1.32 |
| Jun 17 | 231.44 | 227.45 | 233.04 | 2.46 |
| Jun 18 | 236.71 | 234.53 | 240.58 | 2.58 |
| Jun 19 | 236.17 | 232.09 | 237.25 | 2.22 |
| Jun 20 | 238.50 | 234.39 | 241.35 | 2.97 |
| Jun 21 | 240.09 | 236.34 | 241.47 | 2.17 |
| Jun 22 | 234.63 | 230.52 | 237.86 | 3.18 |
| Jun 23 | 235.92 | 232.66 | 239.88 | 3.10 |
| Jun 24 | 233.70 | 229.40 | 236.17 | 2.95 |
Amgen Daily Price Targets
Amgen Stock Forecast 05-26-2022.
Pessimistic target level: 245.65
Optimistic target level: 252.66
Amgen Stock Forecast 05-27-2022.
Pessimistic target level: 247.49
Optimistic target level: 250.70
Amgen Stock Forecast 05-28-2022.
Pessimistic target level: 240.35
Optimistic target level: 246.90
Amgen Stock Forecast 05-29-2022.
Pessimistic target level: 238.19
Optimistic target level: 246.26
Amgen Stock Forecast 05-30-2022.
Pessimistic target level: 244.70
Optimistic target level: 248.62
Amgen Stock Forecast 05-31-2022.
Pessimistic target level: 240.64
Optimistic target level: 247.91
AMGN (AMGN) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 241.52 | 226.74 | 256.59 | 11.63 |
| Jul. | 231.67 | 223.33 | 238.62 | 6.41 |
| Aug. | 221.94 | 209.69 | 230.73 | 9.12 |
| Sep. | 211.55 | 194.80 | 228.31 | 14.68 |
| Oct. | 195.81 | 184.06 | 211.79 | 13.09 |
| Nov. | 196.05 | 180.05 | 202.63 | 11.15 |
| Dec. | 215.10 | 202.71 | 231.62 | 12.48 |
Amgen forecast for this year
Amgen Stock Prediction for Jun 2022
An downtrend is forecast for this month with an optimal target price of $241.523. Pessimistic: $226.74. Optimistic: $256.59
Amgen Stock Prediction for Jul 2022
An downtrend is forecast for this month with an optimal target price of $231.668. Pessimistic: $223.33. Optimistic: $238.62
Amgen Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $221.938. Pessimistic: $209.69. Optimistic: $230.73
Amgen Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $211.552. Pessimistic: $194.80. Optimistic: $228.31
Amgen Stock Prediction for Oct 2022
An downtrend is forecast for this month with an optimal target price of $195.812. Pessimistic: $184.06. Optimistic: $211.79
Amgen Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $196.047. Pessimistic: $180.05. Optimistic: $202.63
Amgen Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $215.103. Pessimistic: $202.71. Optimistic: $231.62
Amgen (AMGN) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 202.71 | 197.36 | 212.93 | 7.31 |
| Feb | 198.09 | 192.39 | 207.84 | 7.43 |
| Mar | 213.78 | 203.01 | 222.50 | 8.76 |
| Apr | 197.11 | 189.54 | 203.73 | 6.97 |
| May | 194.27 | 184.94 | 200.10 | 7.57 |
| Jun | 215.25 | 207.24 | 226.61 | 8.55 |
| Jul | 239.79 | 229.43 | 258.78 | 11.34 |
| Aug | 246.12 | 235.78 | 255.86 | 7.85 |
| Sep | 267.38 | 260.64 | 288.88 | 9.77 |
| Oct | 295.30 | 268.01 | 313.01 | 14.38 |
| Nov | 296.71 | 277.13 | 320.57 | 13.55 |
| Dec | 290.66 | 265.90 | 314.38 | 15.42 |
Amgen (AMGN) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 271.48 | 250.30 | 289.39 | 13.51 |
| Feb | 272.45 | 257.09 | 284.22 | 9.55 |
| Mar | 267.55 | 247.32 | 288.10 | 14.15 |
| Apr | 261.77 | 248.26 | 281.87 | 11.92 |
| May | 272.77 | 261.64 | 289.46 | 9.61 |
| Jun | 287.82 | 269.86 | 300.60 | 10.23 |
| Jul | 276.77 | 260.50 | 303.01 | 14.03 |
| Aug | 282.08 | 274.30 | 294.27 | 6.79 |
| Sep | 297.65 | 282.30 | 319.80 | 11.73 |
| Oct | 265.86 | 257.89 | 275.76 | 6.48 |
| Nov | 248.00 | 234.61 | 257.82 | 9.00 |
| Dec | 223.89 | 207.24 | 235.18 | 11.88 |
Amgen (AMGN) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 221.74 | 210.57 | 228.13 | 7.70 |
| Feb | 216.42 | 199.54 | 227.33 | 12.22 |
| Mar | 216.94 | 211.21 | 234.38 | 9.89 |
| Apr | 222.93 | 205.81 | 230.15 | 10.58 |
| May | 210.09 | 192.69 | 215.13 | 10.43 |
| Jun | 199.50 | 190.16 | 204.77 | 7.13 |
| Jul | 193.04 | 174.97 | 209.25 | 16.38 |
| Aug | 186.32 | 174.47 | 200.40 | 12.94 |
| Sep | 171.79 | 157.15 | 186.01 | 15.52 |
| Oct | 151.58 | 147.22 | 165.23 | 10.90 |
| Nov | 155.40 | 144.21 | 160.63 | 10.22 |
| Dec | 163.05 | 154.83 | 175.57 | 11.81 |
Amgen (AMGN) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 172.83 | 159.97 | 188.80 | 15.27 |
| Feb | 172.00 | 162.92 | 182.12 | 10.54 |
| Mar | 172.42 | 159.38 | 186.48 | 14.53 |
| Apr | 185.86 | 178.06 | 203.71 | 12.59 |
| May | 197.69 | 185.35 | 208.83 | 11.25 |
| Jun | 200.06 | 186.13 | 212.30 | 12.33 |
| Jul | 194.54 | 184.03 | 200.37 | 8.16 |
| Aug | 184.03 | 179.61 | 196.18 | 8.44 |
| Sep | 179.83 | 162.57 | 194.29 | 16.33 |
| Oct | 178.76 | 164.17 | 195.27 | 15.93 |
| Nov | 166.10 | 161.91 | 179.06 | 9.57 |
| Dec | 175.67 | 169.34 | 187.47 | 9.67 |
Amgen information and performance
AMGen is an American biopharmaceutical company and the largest transnational independent biotechnology firm in the world. AMGen is engaged in research in the field of biology, opening up opportunities for patients with serious diseases such as cancer, bone damage, various kidney diseases, autoimmune diseases (in particular rheumatoid arthritis) and other diseases. The company uses progressive methods of gene engineering, which makes it possible to identify the complex pathogenesis of diseases, to comprehend the basics of human biology.
AMGen was founded in 1980, co-founder George B. Ratmann became the first CEO of the company, after several changes of leadership in May 2012, Robert A. Bradway, who has a bachelor’s degree in biology and a master’s degree from Harvard University, took the position. The company has had at least five major corporate acquisitions.
Amgen Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, US
Market Capitalization: 130 275 353 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 12 892 000 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 24.1
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 1.459
Price/earnings to growth
DPS: 7.22
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: 0.0319
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: 10.12
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: -0.053
Quarterly Revenue Growth YOY: 0.057
Trailing PE: 24.1
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 13.77
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 6.12
Enterprise Value (EV) /Revenue
EV To EBITDA: 14.48
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 534200000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Amgen (AMGN) stock dividend
Amgen last paid dividends on 05/16/2022. The next scheduled payment will be on 06/08/2022. The amount of dividends is $7.22 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Factor:
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.